Comparison of Central Nervous System Adverse Effects of Amantadine and Rimantadine Used as Sequential Prophylaxis of Influenza A in Elderly Nursing Home Patients
Open Access
- 22 May 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 160 (10), 1485-1488
- https://doi.org/10.1001/archinte.160.10.1485
Abstract
INFLUENZA A is a common cause of serious respiratory illness in the elderly population.1 Among persons aged 65 years and older, rates of hospitalization for influenza range from 200 to more than 1000 per 100,000 population.1 Immunization with influenza vaccine has been shown to be 50% to 60% effective in preventing hospitalization and pneumonia, 80% effective in preventing death, and 30% to 40% effective in preventing disease in elderly populations. However, because of the limited effectiveness of the vaccine, chemoprophylaxis is often indicated during suspected or confirmed outbreaks.1Keywords
This publication has 5 references indexed in Scilit:
- Amantadine and Rimantadine Prophylaxis of Influenza A in Nursing HomesDrugs & Aging, 1994
- Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokineticsAntimicrobial Agents and Chemotherapy, 1983
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionNew England Journal of Medicine, 1982
- Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramineAntimicrobial Agents and Chemotherapy, 1982
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976